SB 136 amends Montana's criminal code (Section 45-2-211, MCA) to state that a patient's consent to physician aid in dying is not a defense to a homicide charge against the physician. The bill defines "physician aid in dying" as a physician prescribing a lethal medication for the patient to self-administer, excluding standard comfort care or withholding life-sustaining treatment. This directly affects physicians who provide such aid, making their actions prosecutable as homicide if consent is claimed as a defense. The law takes effect July 1, 2025, and does not impact existing practices of comfort care or end-of-life treatment under Montana law.
SB 504 proposes creating a $75 million grant program to fund permanent supportive housing projects in Montana. The bill would provide grants to nonprofit organizations for constructing, rehabilitating, or acquiring housing that offers long-term affordable leases (for residents earning 60% or less of the area median income) and onsite support services like mental health care, job assistance, and addiction recovery. It allocates $50 million from the general fund and $25 million from a behavioral health fund, with grants disbursed based on project proposals and adherence to specific conditions, including outcome tracking. The program, administered by the Montana Department of Commerce, aims to directly support homeless or at-risk individuals through housing and integrated services, effective July 1, 2025. (Note: The bill died in process in May 2025 and did not become law.)
SB 216 creates Montana's Physicians' Workforce Investment Act, establishing a task force to administer grants for health sector facilities (like hospitals) to launch or expand residency and fellowship programs. The grant program provides up to $2 million per facility to support new graduate medical education programs, requiring applicants to submit accreditation plans, 2-year financial projections, and 5-year sustainability strategies. This directly affects Montana hospitals seeking to train medical graduates (those with medical degrees but without residency completion) and aims to address physician shortages by increasing training opportunities. The task force must report annually on grant usage, program locations, specialty fields, and accreditation status to the legislature.
SB 478 would require Montana's public universities to cover medical costs for students who develop specific vaccine-related health conditions after receiving mandated COVID-19 vaccinations. Students would need to submit proof of vaccination (to comply with school attendance rules), a medical diagnosis of one of five listed conditions (like heart inflammation or blood clotting disorders), and cost records to their institution for reimbursement. The bill covers diagnosis, treatment, and lost wages related to those conditions, as defined by the Board of Regents. The bill died in committee in May 2025 and did not become law.
SB 334 would have expanded Montana Medicaid eligibility to able-bodied adults under 65 with incomes at or below 100% of the federal poverty level, but only if they met community engagement requirements. Key provisions include mandating participation in workforce development programs (like job training in healthcare or cybersecurity) and requiring the state to seek federal waiver approval by December 2025. The bill also included measures like biannual eligibility reviews and lifetime benefit limits for this group. However, the bill died in process on May 23, 2025, after failing to advance beyond committee review.
SB 483 would revise Montana's health care laws by adding specific definitions to clarify insurance coverage processes, particularly around "step therapy" protocols. It directly affects health insurance issuers, providers, and patients by standardizing terms like "adverse determination" (denials of coverage), "clinical peer" reviews, and "step therapy" requirements. Key provisions define how insurers must review coverage requests, including requiring medical necessity justifications and establishing clearer pathways for appeals. The bill focuses on improving transparency in insurance decision-making without creating new benefits or funding. (Note: This bill died in process on May 23, 2025, and did not become law.)
SB 417 would require most Montana health insurance plans to cover certain injectable medicines prescribed for glucose control or weight loss in adults diagnosed with prediabetes, gestational diabetes, or obesity. Coverage must be deemed medically necessary by a physician and requires participants to join a lifestyle management program to continue treatment. The bill applies to individual and group health insurance policies but excludes Medicare Advantage plans. It amends Montana insurance law to mandate this coverage as a standard benefit.
SB 164 amends Montana's endangering the welfare of children law to prohibit specific medical treatments for children under 16. The bill bans surgical procedures, puberty blockers, and hormone therapies (like estrogen or testosterone) when used to alter a child's appearance or affirm a gender identity inconsistent with their biological sex. Violating this prohibition is classified as a felony, carrying up to five years in prison and a $10,000 fine, with harsher penalties if the child suffers serious injury. The law would take effect on January 1, 2026, directly affecting medical providers, caregivers, and children under 16 who might receive these treatments.
SB 554 (Montana) limits nonprofit hospitals (excluding critical access/rural emergency hospitals) to charging no more than 300% of the Medicare reimbursement rate for Medicare-eligible services. Hospitals exceeding this rate face an escalating excise tax (starting at 25% in 2027 and rising to 50% after 2030) and risk losing nonprofit status. The bill also requires hospitals to maintain written financial assistance and community benefit policies, submit annual reports including IRS Form 990, and comply with new reporting rules. This bill died in process in May 2025 and was never enacted.
SB 479 proposes to revise Montana laws around chemical abortion by requiring health care providers to physically examine patients, be present during administration, schedule a follow-up within 7 days, and provide disposal kits (catch kits and medical waste bags) for patients to return used materials. It holds manufacturers of abortion drugs responsible for environmental cleanup if drug byproducts contaminate wastewater systems, with fines up to $20,000 per violation. The bill exempts life-threatening medical emergencies and prohibits prosecuting patients for violations. This legislation directly affects health care providers prescribing abortion drugs and pharmaceutical manufacturers, with penalties including felony charges for providers violating the requirements. The bill died in process in May 2025 and was never enacted.
